113 related articles for article (PubMed ID: 26663830)
1. Desmoplastic melanoma: C>Ts and NF-κB.
Rabbie R; Adams DJ
Pigment Cell Melanoma Res; 2016 Mar; 29(2):120-1. PubMed ID: 26663830
[No Abstract] [Full Text] [Related]
2. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway.
Shain AH; Garrido M; Botton T; Talevich E; Yeh I; Sanborn JZ; Chung J; Wang NJ; Kakavand H; Mann GJ; Thompson JF; Wiesner T; Roy R; Olshen AB; Gagnon A; Gray JW; Huh N; Hur JS; Busam KJ; Scolyer RA; Cho RJ; Murali R; Bastian BC
Nat Genet; 2015 Oct; 47(10):1194-9. PubMed ID: 26343386
[TBL] [Abstract][Full Text] [Related]
3. Desmoplastic Melanoma Carries High Mutation Burden.
Cancer Discov; 2015 Nov; 5(11):OF1. PubMed ID: 26432107
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
Ludwig L; Kessler H; Wagner M; Hoang-Vu C; Dralle H; Adler G; Böhm BO; Schmid RM
Cancer Res; 2001 Jun; 61(11):4526-35. PubMed ID: 11389085
[TBL] [Abstract][Full Text] [Related]
5. The Nuclear Protein IκBζ Forms a Transcriptionally Active Complex with Nuclear Factor-κB (NF-κB) p50 and the Lcn2 Promoter via the N- and C-terminal Ankyrin Repeat Motifs.
Kohda A; Yamazaki S; Sumimoto H
J Biol Chem; 2016 Sep; 291(39):20739-52. PubMed ID: 27489104
[TBL] [Abstract][Full Text] [Related]
6. [Tert promoter mutations in melanoma: not only the MAP-kinase pathway].
Dereure O
Ann Dermatol Venereol; 2013; 140(6-7):487-8. PubMed ID: 23773757
[No Abstract] [Full Text] [Related]
7. RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells.
Mezzanotte JJ; Hill V; Schmidt ML; Shinawi T; Tommasi S; Krex D; Schackert G; Pfeifer GP; Latif F; Clark GJ
Epigenetics; 2014 Nov; 9(11):1496-503. PubMed ID: 25482183
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis.
Shishodia S; Koul D; Aggarwal BB
J Immunol; 2004 Aug; 173(3):2011-22. PubMed ID: 15265936
[TBL] [Abstract][Full Text] [Related]
9. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors.
Kralova J; Schatzle JD; Liss AS; Bargmann W; Bose HR
Oncogene; 1996 Jun; 12(12):2595-604. PubMed ID: 8700518
[TBL] [Abstract][Full Text] [Related]
10. A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells.
Dhawan P; Richmond A
J Biol Chem; 2002 Mar; 277(10):7920-8. PubMed ID: 11773061
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice.
Imose M; Nagaki M; Naiki T; Osawa Y; Brenner DA; Asano T; Hayashi H; Kato T; Moriwaki H
Liver Int; 2003 Oct; 23(5):386-96. PubMed ID: 14708901
[TBL] [Abstract][Full Text] [Related]
12. p28(GANK) associates with p300 to attenuate the acetylation of RelA.
Ren YB; Luo T; Li J; Fu J; Wang Q; Cao GW; Chen Y; Wang HY
Mol Carcinog; 2015 Dec; 54(12):1626-35. PubMed ID: 25400040
[TBL] [Abstract][Full Text] [Related]
13. Calcium-dependent regulation of the cell cycle via a novel MAPK--NF-kappaB pathway in Swiss 3T3 cells.
Sée V; Rajala NK; Spiller DG; White MR
J Cell Biol; 2004 Aug; 166(5):661-72. PubMed ID: 15326199
[TBL] [Abstract][Full Text] [Related]
14.
Bai X; Kong Y; Chi Z; Sheng X; Cui C; Wang X; Mao L; Tang B; Li S; Lian B; Yan X; Zhou L; Dai J; Guo J; Si L
Clin Cancer Res; 2017 Oct; 23(20):6120-6127. PubMed ID: 28720667
[No Abstract] [Full Text] [Related]
15. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.
Jeay S; Pianetti S; Kagan HM; Sonenshein GE
Mol Cell Biol; 2003 Apr; 23(7):2251-63. PubMed ID: 12640111
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction. Decoding NF-kappaB signaling.
Ting AY; Endy D
Science; 2002 Nov; 298(5596):1189-90. PubMed ID: 12424362
[No Abstract] [Full Text] [Related]
17. Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice.
Huang S; DeGuzman A; Bucana CD; Fidler IJ
Clin Cancer Res; 2000 Jun; 6(6):2573-81. PubMed ID: 10873114
[TBL] [Abstract][Full Text] [Related]
18. Drug discovery: How melanomas bypass new therapy.
Solit D; Sawyers CL
Nature; 2010 Dec; 468(7326):902-3. PubMed ID: 21164474
[No Abstract] [Full Text] [Related]
19. Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression.
Dhawan P; Singh AB; Ellis DL; Richmond A
Cancer Res; 2002 Dec; 62(24):7335-42. PubMed ID: 12499277
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
